US2010317003A1PendingUtilityA1
Novel compositions and methods in cancer with altered expression of kcnj9
Est. expiryDec 22, 2020(expired)· nominal 20-yr term from priority
A61P 35/00A61K 2039/53C12Q 2600/156C07K 14/705A61P 37/02C12Q 1/6886A61K 38/00C12Q 2600/136G01N 33/57515
40
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast cancers. In addition, the present invention describes the use of novel compositions for use in screening methods.
Claims
exact text as granted — not AI-modified1 - 10 . (canceled)
11 . A method of diagnosing carcinoma comprising:
a) determining the expression of one or more genes comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOS: 1, 2, and 3 in a first tissue type of a first individual; and b) comparing said expression of said gene(s) from a second normal tissue type from said first individual or a second unaffected individual;
wherein a difference in said expression indicates that the first individual has carcinoma.
12 - 19 . (canceled)Join the waitlist — get patent alerts
Track US2010317003A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.